HRT FINANCIAL LP

Position in CLDX — Celldex Therapeutics, Inc.

CIK 1475597 NEW YORK, NY

Position in CLDX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,393,626

-$89,125 QoQ

Shares Held

37,453

-19.9% QoQ

Ownership

0.048%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#110

of 252 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $848,581,551 across 184 Biotechnology names. CLDX ranks #61 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	1,089,376	$81,136,724
2	INSM	INSMED Inc	689,981	$73,565,774
3	EXEL	Exelixis, Inc.	929,242	$50,560,057
4	MDGL	Madrigal Pharmaceuticals, Inc.	84,634	$45,444,226
5	AXSM	Axsome Therapeutics, Inc.	178,491	$43,689,242
6	ARWR	Arrowhead Pharmaceuticals, Inc.	498,655	$40,645,369
7	ABVX	Abivax S.A.	270,612	$36,061,755
8	TGTX	Tg Therapeutics, Inc.	622,603	$34,205,808

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,393,626	37,453	-19.9%	Shares	Defined	2026-08-14
2026-03-31	$1,482,751	46,745	-39.8%	Shares	Defined	2026-05-14
2025-12-31	$2,108,702	77,640	+21.0%	Shares	Defined	2026-02-12
2025-09-30	$1,660,052	64,169	+32.5%	Shares	Defined	2025-11-14
2025-06-30	$985,245	48,415	+126.0%	Shares	Defined	2025-08-14
2025-03-31	$388,736	21,418	+61.7%	Shares	Defined	2025-05-15
2023-12-31	$525,217	13,243	-38.7%	Shares	Defined	2024-02-09
2023-09-30	$594,569	21,605	-69.0%	Shares	Defined	2023-11-13
2022-12-31	$3,110,807	69,796	+240.7%	Shares	Defined	2023-02-10
2021-12-31	$791,617	20,487	-81.4%	Shares	Defined	2022-02-14
2021-03-31	$2,272,303	110,306	+9.3%	Shares	Defined	2021-05-17
2020-12-31	$1,768,100	100,919	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.